SWEDEN’S Public Health Agency has recommended that the protein-based Covid-19 vaccine Nuvaxovid should not be given to people 30 years of age and younger due to increased risk of myocarditis and pericarditis. covidvaccine #sweden

Categories: covid19 • Tags: Sweden, vaccine